Envoy Medical Reaches Critical Milestone in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant
Go back to Envoy Medical Reaches Critical Milestone in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant| (NASDAQ: COCH) | Delayed: 0.65 -0.01 (1.52%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.66 | 52 Week High | $ | |||
| Open | $0.66 | 52 Week Low | $ | |||
| Day High | $0.67 | P/E | N/A | |||
| Day Low | $0.65 | EPS | $ | |||
| Volume | 7,483 | |||||

